Lotus Pharmaceuticals Inc (LTUS)

[butchie64]

Here's my numbers that were pulled from the 10Q's & K's.
IMO, there isn't any reason for alarm due to dilution (yet):
March 30. 2010 50,863,217 shares of common stock issued and outstanding.
Q4 2009: 50.046 diluted share count
Q3 2009: 49.745 diluted share count
Q2 2009: 49.562 diluted share count
Q1 2009: 49.255 diluted share count
Q4 2008: 48.055 diluted share count

From Q1 2009 earnings release:
2009 Earnings Guidance
For the fiscal year 2009, Lotus maintains its forecast of net income to range from $16.6 million and $17.9 million, and expects sales to range from $55.4 to $59.7 million.

Actual 2009 results:
2009 net earnings were approximately $16.4 million so they were a little shy of their forecasted $16.6-17.9 million.
Net revenues were approximately $57.8 million in 2009, so they were right in the middle of what they forecasted.

However, their 2010 forecast of "its EBIT of fiscal year 2010 to grow by 15-20%, because its direct sales of drugs to third-party pharmacies in Beijing are expected to generate additional earnings" seems a little chinsey to me.
Does anyone have any thoughts on this forecast?


keep it fun & enjoy each one
butch